封面
市場調查報告書
商品編碼
1544765

遠距醫療市場、機會、成長動力、產業趨勢分析與預測,2024-2032

Telemedicine Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在電信和數位醫療技術創新的推動下,2024 年至 2032 年間,全球遠距醫療市場規模的複合年成長率將達到 16.4%。高速網際網路、先進的遠距醫療平台和穿戴式健康設備等先進技術使遠距諮詢更加高效和便利。此外,不斷增加的政府支持和有利的法規透過促進遠距醫療融入主流醫療保健進一步推動市場成長。這些支持性措施,加上數位醫療解決方案的推動,將擴大遠距醫療服務,提高醫療保健可近性,並改善患者的治療效果。

例如,2024 年 1 月,北哈薩克地區推出了新的遠距醫療綜合體,以增強農村人口獲得專業醫療諮詢的機會,旨在改善偏遠地區的醫療保健可用性。這項發展凸顯了在全球擴大遠距醫療服務的更廣泛趨勢,旨在縮小醫療保健取得方面的差距,並為服務不足的人群提供專業諮詢。這表明對遠距醫療解決方案的需求不斷成長,以加強醫療保健服務,特別是在農村和偏遠地區,從而推動了全球遠距醫療產業的成長。

遠距醫療市場根據組件、專業、最終用途和地區進行細分。

在糖尿病和甲狀腺疾病等慢性內分泌疾病發病率上升的推動下,內分泌學領域將在 2024 年至 2032 年期間大幅增加。遠距醫療有助於遠端管理和監控,這對於管理此類疾病以及為患者提供及時的護理和定期檢查至關重要。虛擬諮詢的便利性和遠端監控技術的進步正在推動內分泌學的廣泛採用,有助於其在遠距醫療市場中的主導地位。

由於遠距醫療服務的需求不斷成長,到 2032 年,服務領域將顯著成長。這包括虛擬諮詢、遠端診斷和患者監護,為滿足各種醫療保健需求的患者提供便利和可近性。遠距醫療服務的擴展與數位醫療技術的進步相結合,支持高效且有效的護理服務。隨著越來越多的醫療保健提供者採用遠距醫療解決方案,服務領域持續成長,反映出其在市場中的關鍵作用。

由於人口眾多且多樣化、智慧型手機普及率不斷提高以及偏遠地區醫療保健需求不斷成長,亞太地區遠距醫療市場佔有率將在 2024 年至 2032 年實現適度的複合年成長率。該地區的快速城市化,加上政府的支持性舉措和數位醫療基礎設施投資的增加,正在進一步推動遠距醫療的採用。此外,不斷擴大的醫療保健需求和推動創新解決方案來縮小醫療保健獲取差距,使亞太地區成為遠距醫療市場成長的重要貢獻者。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 慢性病盛行率增加
      • 智慧型手機用戶數量不斷成長
      • 與行動電話和網際網路相關的技術進步
      • 更需要節省醫療服務成本
      • 有利的政府措施國家
    • 產業陷阱與挑戰
      • 安全和隱私問題
  • 成長潛力分析
  • 報銷場景
    • 美國
    • 歐洲
  • 遠距醫療方式
  • 遠距醫療項目
  • 遠距醫療舉措
  • 遠距醫療未來趨勢
  • 分析師建議
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按組成部分,2021 - 2032 年

  • 主要趨勢
  • 硬體
  • 軟體
    • 基於雲端
    • 本地
  • 服務
    • 遠距諮詢
    • 遠端監控
    • 遠距教育/培訓
    • 其他服務

第 6 章:市場估計與預測:按專業分類,2021 - 2032 年

  • 主要趨勢
  • 肺部
  • 精神病學
  • 心臟病學
  • 內分泌科
  • 風濕病學
  • 婦科
  • 胃腸病學
  • 腫瘤學
  • 其他專業

第 7 章:市場估計與預測:按最終用戶分類,2021 - 2032 年

  • 主要趨勢
  • 醫療保健提供者
    • Hospitals and clinics
    • Long-term care centers
    • Other healthcare facilities
  • 付款人
  • 患者
  • 其他最終用戶

第 8 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 波蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 9 章:公司簡介

  • AMC Health
  • AMD Global Telemedicine
  • American Well (Amwell)
  • Cisco Systems, Inc.
  • Eagle Telemedicine
  • GE HealthCare Technologies, Inc.
  • Health Catalyst Inc.
  • HIPAAVIDEO.net, Inc.
  • Honeywell International Inc
  • Koninklijke Philips N.V
  • Masimo Corporation
  • McKesson Medical-Surgical Inc.
  • Mend
  • OBS Medical
  • Oracle Corporation (Cerner)
  • RemetricHealth
  • SOC Telemed (Patient Square Capital)
  • Specialist Telemed
  • Teladoc Health, Inc.
  • Updox
  • VCDoctor
  • Veradigm LLC (Allscripts Healthcare Solutions Inc.)
簡介目錄
Product Code: 3129

Global Telemedicine Market size will capture a 16.4% CAGR between 2024 and 2032, driven by innovations in telecommunication and digital health technologies. Advances, such as high-speed internet, sophisticated telemedicine platforms, and wearable health devices enable more efficient and accessible remote consultations. Also, increasing government support and favorable regulations further drive market growth by facilitating the integration of telemedicine into mainstream healthcare. These supportive measures, along with a push for digital health solutions, will expand telemedicine services, enhance healthcare accessibility, and improve patient outcomes.

For instance, in January 2024, the North Kazakhstan Region introduced new telemedicine complexes to enhance access to specialized medical consultations for its rural population, aiming to improve healthcare availability in remote areas. This development underscores a broader trend of expanding telemedicine services globally, aiming to bridge gaps in healthcare access and provide specialized consultations to underserved populations. It indicates a rising demand for telemedicine solutions to enhance healthcare delivery, particularly in rural and remote regions, driving growth in the global telemedicine industry.

The telemedicine market is segmented based on component, specialty, end-use, and region.

The endocrinology segment will witness substantial growth throughout 2024-2032, fueled by the rising incidence of chronic endocrine conditions like diabetes and thyroid disorders. Telemedicine facilitates remote management and monitoring, essential for managing such conditions and providing patients with timely access to care and regular check-ups. The convenience of virtual consultations and advancements in remote monitoring technology are driving increased adoption in endocrinology, thereby contributing to its dominant position in the telemedicine market.

The services segment will amass remarkable gains by 2032, owing to the growing demand for remote healthcare services. This includes virtual consultations, remote diagnostics, and patient monitoring, which provide convenience and accessibility for patients across various healthcare needs. The expansion of telehealth services, in tandem with advancements in digital health technologies, supports efficient and effective care delivery. As more healthcare providers adopt telemedicine solutions, the services segment continues to grow, reflecting its pivotal role in the market.

Asia Pacific telemedicine market share will achieve a moderate CAGR from 2024 to 2032 due to its large and diverse population, increasing smartphone penetration, and growing demand for healthcare access in remote areas. The region's rapid urbanization, in line with supportive government initiatives and rising investments in digital health infrastructure, is further driving telemedicine adoption. Besides, the expanding healthcare needs and the push for innovative solutions to bridge gaps in healthcare access establish Asia Pacific as a significant contributor to the telemedicine market growth.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360º synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Growing number of smartphone users
      • 3.2.1.3 Technological advancements related to mobile phones and internet
      • 3.2.1.4 Greater need for cost-saving in healthcare delivery
      • 3.2.1.5 Favorable government initiatives countries
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Security and privacy concerns
  • 3.3 Growth potential analysis
  • 3.4 Reimbursement scenario
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Telemedicine modalities
  • 3.6 Telemedicine projects
  • 3.7 Telemedicine initiatives
  • 3.8 Telemedicine future trends
  • 3.9 Analyst recommendations
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hardware
  • 5.3 Software
    • 5.3.1 Cloud-based
    • 5.3.2 On-premises
  • 5.4 Services
    • 5.4.1 Tele-consultation
    • 5.4.2 Tele-monitoring
    • 5.4.3 Tele-education/training
    • 5.4.4 Other services

Chapter 6 Market Estimates and Forecast, By Specialty, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Pulmonary
  • 6.3 Psychiatry
  • 6.4 Cardiology
  • 6.5 Endocrinology
  • 6.6 Rheumatology
  • 6.7 Gynecology
  • 6.8 Gastroenterology
  • 6.9 Oncology
  • 6.10 Other specialties

Chapter 7 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Healthcare providers
    • 7.2.1 Hospitals and clinics
    • 7.2.2 Long-term care centers
    • 7.2.3 Other healthcare facilities
  • 7.3 Payers
  • 7.4 Patients
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Poland
    • 8.3.7 Belgium
    • 8.3.8 Sweden
    • 8.3.9 Switzerland
    • 8.3.10 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 AMC Health
  • 9.2 AMD Global Telemedicine
  • 9.3 American Well (Amwell)
  • 9.4 Cisco Systems, Inc.
  • 9.5 Eagle Telemedicine
  • 9.6 GE HealthCare Technologies, Inc.
  • 9.7 Health Catalyst Inc.
  • 9.8 HIPAAVIDEO.net, Inc.
  • 9.9 Honeywell International Inc
  • 9.10 Koninklijke Philips N.V
  • 9.11 Masimo Corporation
  • 9.12 McKesson Medical-Surgical Inc.
  • 9.13 Mend
  • 9.14 OBS Medical
  • 9.15 Oracle Corporation (Cerner)
  • 9.16 RemetricHealth
  • 9.17 SOC Telemed (Patient Square Capital)
  • 9.18 Specialist Telemed
  • 9.19 Teladoc Health, Inc.
  • 9.20 Updox
  • 9.21 VCDoctor
  • 9.22 Veradigm LLC (Allscripts Healthcare Solutions Inc.)